Found: 35
Select item for more details and to access through your institution.
Outcome prediction by the knowledge bank approach in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 10, p. E382, doi. 10.1002/ajh.26653
- By:
- Publication type:
- Article
Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 10, p. 1287, doi. 10.1002/ajh.26298
- By:
- Publication type:
- Article
Clinical value of the measurable residual disease status within the ELN2017 risk groups in AML patients undergoing allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E237, doi. 10.1002/ajh.26179
- By:
- Publication type:
- Article
Comparison of non‐myeloablative and reduced‐intensity allogeneic stem cell transplantation in older patients with myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. 1344, doi. 10.1002/ajh.25636
- By:
- Publication type:
- Article
Prognostic impact of the CD34+/CD38− cell burden in patients with acute myeloid leukemia receiving allogeneic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 388, doi. 10.1002/ajh.24663
- By:
- Publication type:
- Article
Clinical Implications of the FLT3 -ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1312, doi. 10.3390/cancers15041312
- By:
- Publication type:
- Article
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5679, doi. 10.3390/cancers13225679
- By:
- Publication type:
- Article
Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1625, doi. 10.3390/cancers11111625
- By:
- Publication type:
- Article
Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 9, p. e277, doi. 10.1016/j.clml.2024.05.006
- By:
- Publication type:
- Article
P-185: Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 myeloma patients: a retrospective real-world study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S138, doi. 10.1016/S2152-2650(21)02312-0
- By:
- Publication type:
- Article
Extramedullary Clonal Hematopoiesis with Indeterminate Potential.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 9, p. e696, doi. 10.1016/j.clml.2021.04.008
- By:
- Publication type:
- Article
Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00764-9
- By:
- Publication type:
- Article
Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Meningokokkensepsis ohne Liquorpathologie unter Eculizumabtherapie.
- Published in:
- Medizinische Klinik: Intensivmedizin & Notfallmedizin, 2020, v. 115, n. 4, p. 340, doi. 10.1007/s00063-019-0552-0
- By:
- Publication type:
- Article
Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after Rituximab in children and young adults.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 5, p. 823, doi. 10.1002/pbc.25398
- By:
- Publication type:
- Article
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 547, doi. 10.1007/s00277-023-05087-8
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 10, p. 2417, doi. 10.1007/s00277-020-04235-8
- By:
- Publication type:
- Article
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Management of Patients Undergoing CAR-T Cell Therapy in Germany.
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 3, p. 65, doi. 10.1159/000536201
- By:
- Publication type:
- Article
Case Report: Large Granular Lymphocyte Leukemia (LGLL)—A Case Series of Challenging Presentations.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.775313
- By:
- Publication type:
- Article
Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.749691
- By:
- Publication type:
- Article
Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.737645
- By:
- Publication type:
- Article
Steady‐state versus chemotherapy‐based hematopoietic cell mobilization after anti‐CD38‐based induction therapy in newly diagnosed multiple myeloma.
- Published in:
- Transfusion, 2023, v. 63, n. 11, p. 2131, doi. 10.1111/trf.17566
- By:
- Publication type:
- Article
Analysis of stem cell collections in adult patients with Ewing sarcoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6131, doi. 10.1007/s00432-023-04587-4
- By:
- Publication type:
- Article
Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 3739, doi. 10.1007/s00432-022-04184-x
- By:
- Publication type:
- Article
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 8, p. 2349, doi. 10.1007/s00432-020-03504-3
- By:
- Publication type:
- Article
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 12, p. 2545, doi. 10.1007/s00432-017-2504-5
- By:
- Publication type:
- Article
Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 10, p. 2049, doi. 10.1007/s00432-017-2439-x
- By:
- Publication type:
- Article
Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 1, p. 317, doi. 10.1007/s00432-015-2050-y
- By:
- Publication type:
- Article
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 11, p. 2013, doi. 10.1007/s00432-015-1984-4
- By:
- Publication type:
- Article
Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01746
- By:
- Publication type:
- Article
Allogeneic Hematopoietic Stem Cell Transplantation in a Rare Case of Tonsillar Mast Cell Sarcoma.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00219
- By:
- Publication type:
- Article